People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Other Health Care, Healthtech, Other Technology, Manufacturing, Investment Vehicle, Mining & Resources
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| IRC Parent, Inc. | — | Other Health Care | Series B | $40.5M | $31.3M | 2019 |
| Third Eye Health, Inc. | — | Healthtech | Series A | $28.4M | $40.8M | 2018 |
| Assisted 4 Living, Inc. | — | Other Health Care | Series A | $8.8M | $62.2M | 2021 |
| Katalyst Inc. | — | Other Technology | Series A | $7.1M | $154.7M | 2016 |
| Unified CML Operations, LLC | — | Manufacturing | Seed | $2.1M | $26.1M | 2011 |
| Electus Investment Fund I, LLC | — | Investment Vehicle | Seed | $1.5M | $27.9M | 2019 |
| Conduit Venture Labs Holdings I, LLC | — | Investment Vehicle | Pre-Seed | $730K | $3.3M | 2024 |
| Trigon Metals Inc. | — | Mining & Resources | Pre-Seed | $640K | $1.1M | 2012 |
AMISH PATEL at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside AMISH PATEL on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| DAVID SHAW | 1 | 12 |
| Russell Hirsch | 1 | 10 |
| Rachel Kern | 1 | 7 |
| Paul Bozoki | 1 | 5 |
| Bruce Cassidy | 1 | 5 |
| ALEXANDER HELMEL | 1 | 4 |
| ROGER TICHENOR | 1 | 3 |
| Priscila Bala | 1 | 3 |
| Kirsten Morbeck | 1 | 3 |
| Michael Valentino | 1 | 3 |
| Steven Lefar | 1 | 3 |
| Michael Sachs | 1 | 3 |
| Janet Huffman | 1 | 3 |
| Gabriel Ollivier | 1 | 2 |
| Steve Lefar | 1 | 2 |
| David Reis | 1 | 2 |
| Daye Kaba | 1 | 2 |
| Mary Kate Salley | 1 | 2 |
| Jamison Feramisco | 1 | 2 |
| BJOERN WOLTERMANN | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.